fda approval in cll and fl, partial hold lifted in tazmetostat trials, and more
Published 6 years ago • 162 plays • Length 11:13
Download video MP4
Download video MP3
Similar videos
-
11:34
fda approval in cll, recommendation in sts, partial hold on cervical cancer trial, and more
-
13:36
fda approval in prostate cancer, nda submitted in cll and follicular lymphoma, and more
-
7:26
fda approval in ovarian cancer, priority reviews in nsclc, cll, and follicular lymphoma, and more
-
9:46
fda approval in cll, recommendation in nsclc, missed endpoint in gbm study, and more
-
5:21
fda approvals in cll and all, nda accepted in melanoma, and more
-
9:41
fda approvals in follicular lymphoma and prostate cancer, biosimilar is granted approval, and more
-
9:35
fda approvals in breast cancer and of a biosimilar, nda submitted in cll, and more
-
24:22
highlight of cll-related 2016 fda approvals: venetoclax
-
8:10
fda approval for cll, odac vote in lung cancer, european regulatory advances, and more
-
29:14
ibrutinib resistance-mechanisms and options in cll
-
10:35
fda approval in aml, nda submitted in myeloma, clinical hold on car t-cell therapy trials, and more
-
1:06
dr. flinn on the fda approval of duvelisib in cll and follicular lymphoma
-
53:40
finding treatment synergy in cll
-
2:07
dr. ferrajoli on the fda approval of ibrutinib in cll
-
9:08
fda approvals in cervical cancer, ovarian cancer, and cll, and more
-
9:42
fda approval in lung cancer, promising findings in hodgkin lymphoma, and more
-
0:31
preview: fda approvals in cll and all, nda accepted in melanoma, and more
-
0:33
onclive news network preview: fda approval in head and neck cancer
-
9:10
fda approvals in cml and hodgkin lymphoma, priority review in crc, and more
Clip.africa.com - Privacy-policy